logo

Intellia Therapeutics, Inc. (NTLA)



Trade NTLA now with
  Date
  Headline
3/15/2018 7:26:52 AM Wedbush Is Cutting Intellia Therapeutics, Inc. (NTLA) Q2 18 Estimate To -0.67 From -0.57
3/15/2018 7:26:25 AM Wedbush Is Cutting Intellia Therapeutics, Inc. (NTLA) Q1 18 Estimate To -0.64 From -0.55
3/15/2018 7:25:55 AM Wedbush Reiterates Intellia Therapeutics, Inc. (NTLA) At Outperform With $36 Price Target
3/14/2018 7:34:55 AM Intellia Therapeutics Q4 Net Loss $24.0 Mln Vs Loss $10.6 Mln Last Year
11/1/2017 7:57:39 AM Wedbush Is Lowering Intellia Therapeutics, Inc. (NTLA) 2018 Estimate To -1.75 From -1.72
11/1/2017 7:57:23 AM Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) 2017 Estimate To -1.72 From -1.76
9/27/2017 10:15:49 AM Wedbush Reiterates Intellia Therapeutics, Inc. (NTLA) At Ourperform With $29 Up From $25 Price Target
5/15/2017 6:55:28 PM Wedbush Reiterates Intellia Therapeutics, Inc. (NTLA) At Outperform With $25 Price Target
5/3/2017 9:07:22 AM Wedbush Reiterates Intellia Therapeutics, Inc. (NTLA) At Outperform With $25 Price Target
5/3/2017 9:06:53 AM Wedbush Is Cutting Intellia Therapeutics, Inc. (NTLA) 2018 Estimate To -1.45 From -1.24
5/3/2017 9:06:39 AM Wedbush Is Lowering Intellia Therapeutics, Inc. (NTLA) 2017 Estimate To -1.61 From -1.48
5/3/2017 9:06:20 AM Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) 2017 Rev. Estimate To 23.0 M From 21.8 M
3/14/2017 2:50:08 PM Wedbush Reiterates Intellia Therapeutics, Inc. (NTLA) At Outperform With $25 Price Target
3/14/2017 2:49:29 PM Wedbush Is Lowering Intellia Therapeutics, Inc. (NTLA) 2017 Estimate To -1.48 From -1.20
2/16/2017 10:58:07 AM Wedbush Reiterates Intellia Therapeutics, Inc. (NTLA) At Outperform With $25 Price Target
2/16/2017 10:57:13 AM Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) 2017 Estimate To -1.20 From -1.26
2/16/2017 10:56:53 AM Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) 4Q17 Estimate To -0.29 From -0.30
2/16/2017 10:56:37 AM Wedbush Is Raising Intellia Therapeutics, Inc. (NTLA) 3Q17 Estimate To -0.32 From -0.34
2/16/2017 10:56:27 AM Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) 2Q17 Estimate To -0.31 From -0.32